NVIV

InVivo Therapeutics Holdings Corp

Delisted

NVIV was delisted on the 12th of February, 2024.

37 hedge funds and large institutions have $15.9M invested in InVivo Therapeutics Holdings Corp in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$11K
Puts
$117K
Net Calls
Net Calls Change

Top Buyers

1 +$1.31M
2 +$1.09M
3 +$434K
4
ECM
Element Capital Management
New York
+$368K
5
Goldman Sachs
Goldman Sachs
New York
+$251K

Top Sellers

1 -$3.71M
2 -$987K
3 -$805K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$562K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$420K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.5M
2
$1.58M
3
$1.36M
4
$1.14M
5
$1.08M
6
$1.08M
7
$1.06M
8
$1.04M
9
$762K
10
$485K
11
$452K
12
$434K
13
$393K
14
$368K
15
$225K
16
$161K
17
$159K
18
$159K
19
$139K
20
$133K
21
$124K
22
$111K
23
$105K
24
$93K
25
$82K